That number is likely even higher today when you consider that the same survey found that 32% of adults in 2024 said they've "heard a lot" about the drugs, up from 19% year over year
"These products are often positioned as over-the-counter options that mimic the effects of GLP-1 medications, particularly for appetite control and weight management," says Catherine Metzgar, PhD, RD, director of coaching at Virta Health
Most obesity drugs may suppress appetite or food absorption, but only few actually stimulate fat metabolism like the peptide AOD-9604, which has also been tested as an obesity drug in humans
The published literature on this combination draws on the extensive individual evidence bases for both components, with the dual-pathway synergy mechanistically supported by peer-reviewed porcine and in vitro data
You may change the store at any time.
This research is still expanding, with much of the current evidence coming from preclinical studies and Phase 2 and Phase 3 clinical trials